ALLR - Allarity Therapeutics GAAP EPS of -$10.26 March, 08 2024 08:44 AM Allarity Therapeutics Inc. 2024-03-08 08:44:33 ET More on Allarity Therapeutics Allarity Therapeutics appoints co-founder Thomas Jensen as interim CEO Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial information for Allarity Therapeutics For further details see: Allarity Therapeutics GAAP EPS of -$10.26